PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico City, Mexico.\', \'Laboratorio de Inmunobiología y Genética, Instituto Nacional de Enfermedades Respiratorias \'Ismael Cosío Villegas\', Mexico City, Mexico.\', \'Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de México, Mexico City, Mexico.\', \'Departamento de Neuropatología, Instituto Nacional de Neurología y Neurocirugía \'Manuel Velasco Suarez\', Mexico City, Mexico.\', \'Department of Pathology, Instituto Nacional de Enfermedades Respiratorias \'Ismael Cosío Villegas\', Mexico City, Mexico.\', \'Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Mexico City, Mexico.\', \'Posgrado en Ciencias Biológicas, Universidad Nacional Autónoma de México, Mexico City, Mexico.\', \'Department of Virology, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.\', \'Subdirection of Surgery, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.\', \'Departments of Dermatology and Education, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.\', \'Centro Especializado en Neurocirugía y Neurociencias México (CENNM), Mexico City, Mexico.\', \'Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.\', \'Respiratory Critical Care Unit, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City, Mexico.\', \'Department of Molecular Microbiology, Washington University School of Medicine in St Louis, St. Louis, MO, United States.\', \'Department of Physiology & Biophysics School of Medicine, Institute for Immunology, University of California, Irvine, CA, United States.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.3389/fimmu.2021.633297
?:doi
?:hasPublicationType
?:journal
  • Frontiers in immunology
is ?:pmid of
?:pmid
?:pmid
  • 33717172
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.803
?:rankingScore_hIndex
  • 69
is ?:relation_isRelatedTo_publication of
?:title
  • CXCL17 Is a Specific Diagnostic Biomarker for Severe Pandemic Influenza A(H1N1) That Predicts Poor Clinical Outcome.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33717172>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33717172>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all